Viewing Study NCT01121133


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-04-30 @ 8:27 PM
Study NCT ID: NCT01121133
Status: COMPLETED
Last Update Posted: 2017-11-21
First Post: 2010-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Including Chronic Lymphocytic Leukemia View
None Solid Tumors View
Keywords: